You are here: Industry Insights > Astex

News List

Recro Pharma, Astex Enter Drug Development Alliance contractpharma
May 19, 2021
Recro Pharma, Inc., a CDMO providing services for complex formulation and manufacturing challenges for oral solid dose drug products, has signed a new development agreement with Astex Pharmaceuticals, Inc.
Merck collaborates on small molecule inhibitors with Taiho and Astex pharmaceutical-technology
January 09, 2020
Merck has signed an exclusive worldwide research collaboration and licence agreement with two Otsuka Pharmaceutical subsidiaries, Japanese Taiho Pharmaceutical and UK-based Astex Pharmaceuticals.
Astex Pharmaceuticals and Otsuka Announce Results of the Phase 3 ASCERTAIN Study of the Novel Oral Cedazuridine and Decitabine Fixed-Dose Combination (ASTX727) in Patients with Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML) drugs
June 13, 2019
Astex Pharmaceuticals and Otsuka Announce Results of the Phase 3 ASCERTAIN Study of the Novel Oral Cedazuridine and Decitabine Fixed-Dose Combination (ASTX727) in Patients with Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML).
Astex to Install Thermo Fisher's Glacios Cryo-TEM contractpharma
May 22, 2018
Thermo Fisher Scientific announced Astex Pharmaceuticals, a leader in innovative drug discovery and development,
Cancer Research UK and Newcastle University extend drug discovery partnership with Astex pharmaceutical-technology
August 21, 2017
Cancer Research UK and Newcastle University have extended their strategic drug discovery alliance with Astex Pharmaceuticals for three years.The parties will have the provision to further extend their alliance towards the end of the three-year period.